What is BDD Pharma?
BDD Pharma operates as a dual-function CRO and CDMO, providing a comprehensive suite of services that encompass oral drug formulation, GMP manufacturing, and clinical trial management. The company distinguishes itself through its Lean Clinical Development methodology, a strategic framework designed to compress timelines and mitigate the financial risks inherent in early-stage drug discovery. By maintaining a collaborative, client-centric approach, BDD Pharma effectively serves as an extension of its partners' internal R&D teams, facilitating a seamless transition from laboratory concepts to clinical reality. Its market position is reinforced by a long-standing reputation for technical precision and regulatory compliance, making it a preferred collaborator for firms navigating the complexities of modern drug development.
How much funding has BDD Pharma raised?
BDD Pharma has raised a total of $2.5M across 1 funding round:
Other Financing Round
$2.5M
Other Financing Round (2023): $2.5M with participation from Scottish Enterprise, Archangels, and British Business Bank
Key Investors in BDD Pharma
Scottish Enterprise
Scottish Enterprise is Scotland's national economic development agency, providing investment and support to help businesses scale and innovate within the region.
Archangels
Archangels is a prominent investment group focused on supporting high-growth technology and life sciences companies through strategic capital and operational guidance.
British Business Bank
The British Business Bank is a government-owned development bank dedicated to increasing the supply of finance to smaller businesses and supporting economic growth across the UK.
What's next for BDD Pharma?
With the successful closure of this major strategic investment, BDD Pharma is well-positioned to scale its operational capacity and further enhance its integrated service offerings. The capital will likely be deployed to bolster its GMP manufacturing capabilities and expand its clinical trial support infrastructure, allowing the firm to accommodate a larger volume of complex projects. As the pharmaceutical industry continues to prioritize cost-effective and rapid development pathways, BDD Pharma's focus on lean methodologies provides a distinct competitive advantage. Future growth will likely center on deepening its footprint in the global biopharmaceutics market, leveraging its established reputation to secure high-value partnerships and drive innovation in oral drug delivery systems.
See full BDD Pharma company page
